Form D · Other Health Care

Telesis Bio Inc.

San Diego, CA · CIK 0001850079

Offering snapshot reported Jun 20, 2023 · SEC filing

Reported sold
$28M
Offering amount: $74.2M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 5, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 20, 2023Initial$28,000,000No comparison4SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$850K
Finders' fees
$0
Form D file number
021-484651
$46,200,000 common stock available for issuance upon exercise of Common Stock Warrant

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
H.C. Wainwright & Co., LLC375

Source: Form D, filed Jun 20, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert H. Cutler Executive
Eric Esser Executive
Daniel G. Gibson Executive
Andrea L. Jackson Director
Paul Meister Director
Jami Nachtsheim Director
Todd R. Nelson Director, Executive
William F. Snider Director
Christine A. Tsingos Director
Annette V. Tumolo Director
Franklin R. Witney Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
10431 Wateridge Circle Suite 150
San Diego, CA, 92121